Piramal Enterprises hit with nearly $172 million tax bill for pharma deal

Piramal Enterprises has been hit with a nearly $172 million tax bill for a pharma deal. This tax bill highlights the importance of accurate tax compliance in corporate transactions. It underscores the need for proper documentation and accounting. This move reflects the authorities' efforts to enforce tax regulations. It emphasizes the need for thorough audits. The bill aims to ensure compliance and recover revenue.